Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.
- Citation:
- Ann Oncol vol 18 (6) 1071-9
- Year:
- 2007
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 792
- Children:
- None
- Pharmas:
- Grants:
- CA03927, CA04326, CA07968, CA11789, CA12046, CA12449, CA26806, CA31946, CA32291, CA33601, CA35113, CA41287, CA45389, CA45808, CA47642, CA77440, CA77597, CA77651, CA77658
- Corr. Author:
- Authors:
- N L Bartlett D Niedzwiecki J L Johnson J W Friedberg K B Johnson K van Besien A D Zelenetz B D Cheson G P Canellos
- Networks:
- Study
- CALGB-59804
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1/2
- Keywords:
- Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Bleomycin, Dacarbazine, Deoxycytidine, Disease-Free Survival, Dose-Response Relationship, Drug, Doxorubicin, Hodgkin Disease, Humans, Middle Aged, Neutropenia, Patient Selection, Polyethylene Glycols, Salvage Therapy, Survival Analysis, Thrombocytopenia, Treatment Outcome, Vinblastine